Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution.

Saved in:
Bibliographic Details
Title: Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: survey from a single institution.
Authors: Magagnoli M; Department of Medical Oncology and Hematology, Istituto Clinico Humanitas, Rozzano-Milan, Italy. massimo.magagnoli@humanitas.it, Castagna L, Balzarotti M, Sarina B, Timofeeva I, Bertuzzi A, Compasso S, Nozza A, Siracusano L, Santoro A
Source: American journal of hematology [Am J Hematol] 2003 Aug; Vol. 73 (4), pp. 267-72.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print Cited Medium: Print ISSN: 0361-8609 (Print) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0361-8609
DOI:10.1002/ajh.10384